All Work

Chris Lange

Why Argus Is Taking a Step Back on Gilead Sciences

Gilead Sciences, Inc. (NASDAQ: GILD) saw its shares take a step back on Monday after an independent research firm downgraded the stock. Many investors have been hoping that the shares will pull out of…

Chris Lange · 9 years ago

Tyson Takes a Big Bite Out of Earnings

Shares of Tyson Foods saw a handy gain to kick off the week after the company announced its fiscal fourth-quarter financial results, as well as the completion of an acquisition.

Chris Lange · 9 years ago

Why Roku Shares Are Surging

Roku shares absolutely exploded last week, and they don’t seem to be slowing down. Shares surged Monday following the announcement of a key licensing deal.

Chris Lange · 9 years ago

NVIDIA Earnings Push Shares to All-Time High

While the tech sector has been rallying NVIDIA has been at the forefront, leading the way. And it seems that the firm has done it again with a spectacular earnings report.

Chris Lange · 9 years ago

Short Sellers Back Way Off Major Pharma

The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.

Chris Lange · 9 years ago

Is Disney In Trouble After This Report?

The Walt Disney Co. (NYSE: DIS) reported its most recent quarterly results after the markets closed on Thursday. The Mouse House said that it had $1.07 in earnings per share (EPS) and $12.78 billion…

Chris Lange · 9 years ago

Sage Therapeutics Wins Big in Depression Trial

Sage Therapeutics shares absolutely exploded on Thursday after the firm announced top-line results from its late-stage trial in severe postpartum depression.

Chris Lange · 9 years ago